Once Versus Twice Daily Mesalamine to Induce Remission in Pediatric Ulcerative Colitis
Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate effectiveness of once daily dosing of Pentasa
compared with twice daily in children with mild to moderate active ulcerative colitis.